HPV's link to head and neck cancer examined.(Cutaneous
Oncology)
SAN FRANCISCO -- While the relationship of the human papillomavirus
to cervical cancer is well known among the public and in the medical
profession, it is less commonly recognized that oral HPV . . .
Confocal laser microscopy gaining momentum.(Cutaneous
Oncology)
MONTREAL -- Formation of an international confocal microscopy
group, software that aids the detection and mapping of skin lesions, and
introduction of a handheld device are among recent advances to . . .
Melanoma regression alone doesn't justify an SLN
biopsy.(Cutaneous Oncology)
MONTREAL -- Regression of a thin melanoma should not be the sole
criterion to justify a sentinel lymph node biopsy, according to a
retrospective study.
Regression alone is insufficient in the . . .
Gene therapy promising for cutaneous lymphoma.(Cutaneous
Oncology)
KYOTO, JAPAN -- Intratumoral interferon-gamma gene therapy
delivered via an adenoviral vector induces systemic as well as local
immune responses in patients with primary cutaneous T- or . . .
Slashing research money won't help, may hurt.(Guest
Editorial)
Times are tough ... belts must be tightened ... everyone should
sacrifice. These are the messages Congress conveys as it debates the
next year's federal budget. But indiscriminate . . .
Second impressions.(Under My Skin)(medical consultation;
physician-patient interaction)
My first contact with Denise was a ringing beeper at 4:30 a.m.
"My ache is out of control," her voice mail message said.
"The antibiotic I'm on isn't helping. I get to work at
5:30."
Predawn . . .
A perfect bookend.(Guest Editorial)(Genetic Information
Nondiscrimination Act)
The passage of the Genetic Information Nondiscrimination Act in
late May, ushered in what Sen. Edward Kennedy (D-Mass.) called "the
first civil rights bill of the new century of the life . . .
Texting patients may boost topical Tx compliance.(News)
KYOTO, JAPAN -- Daily cell phone text message reminders to slather
on sunscreen doubled the adherence rate in a randomized controlled
trial.
"Text messaging could be a low-cost, effective model . . .
New drugs show promise for CTCL treatment.(News)
KYOTO, JAPAN -- Investigational anticancer agents romidepsin and
forodesine showed promising efficacy in refractory cutaneous T-cell
lymphoma in multicenter phase II clinical trials presented at . . .
Hemangioma distribution may help predict PHACES
risk.(News)(Clinical report)
KYOTO, JAPAN -- The distribution of large facial hemangiomas
appears to be helpful in identifying infants at risk for PHACES
syndrome, according to a first-of-its-kind multicenter . . .
Propranolol found to rapidly shrink severe
hemangiomas.(News)
DESTIN, FLA. -- Propranolol appears to have impressive beneficial
effects on severe hemangiomas of infancy, according to a letter in the
New England Journal of Medicine.
"Keep your eyes out for . . .
Foundation awards $5 million in grants.(News)
The Dermatology Foundation announced its highest allocation ever,
$5.25 million, for dermatologic research. Sixty-seven individuals and
projects are receiving funding, including $55,000/year for up . . .
Incentives, penalties predicted to push doctors to
e-prescribing.(News)
Federal officials are urging physicians to begin electronic
prescribing as soon as possible now that Congress has authorized bonus
payments for the successful use of the technology.
Under the . . .
Medicare nixes payment for more 'never' events:
'this is about changing hospitals and making them safer
places.'.(News)(Report)
Starting Oct. 1, Medicare won't pay for a total of 11
preventable conditions acquired during a hospital stay, up from the
current 8 such conditions. Added to the list of noncovered . . .
From coal tar to phototherapy, psoriasis treatments
revealed.(News)
CHICAGO -- A topical coal-tar solution that doesn't smell, a
user-friendly hydrogel patch, and supraerythemogenic phototherapy were
among the innovative approaches to psoriasis discussed at the . . .
Emerging data link psoriasis to comorbidities.(News)
SAN DIEGO -- Emerging scientific data on adults with psoriasis
suggest the disease engenders a number of comorbidities, including
metabolic syndrome and myocardial infarction.
People with . . .
Efalizumab effective in psoriatic nonresponders.(News)
CHICAGO -- Treatment with efalizumab can benefit patients with
plaque psoriasis who have failed previous treatments with anti-tumor
necrosis factor therapies.
In a single-arm, open-label phase IV . . .
New scleroderma subtypes provide disease
insight.(News)(Disease/Disorder overview)
KYOTO, JAPAN -- One in five patients with clinical symptoms
characteristic of systemic sclerosis does not fit into the popular
classification scheme that divides the disease into the diffuse . . .
Median income for dermatologists.(VITAL SIGNS)
Median Income for Dermatologists
Actual Adjusted *
2003 $285,692 $267,370
2004
2005
2006
2007 $365,524 $303,572
* Adjusted for inflation to 2000 dollars; . . .
Alefacept fails alopecia areata test.(News)(Clinical
report)
CHICAGO -- Alefacept fared no better than placebo in treating
chronic, severe alopecia areata in a 12-week double-blind, randomized
study of 45 adults.
Patients with at least a 6-month history of . . .
|
|